Intellia Therapeutics
Gareth Thomas ACMA CGMA is a finance professional with extensive experience in financial planning and analysis. Currently serving as Sr Director FP&A at Intellia Therapeutics, Inc., Gareth has held various leadership roles at Biogen, including Director and Associate Director of Business Planning. Prior positions include Associate Director BPA at Novartis Vaccines and Diagnostics, Global Tech Ops - Business Process Manager at Novartis Animal Health, and Head Diagnostics BPA for Region EMEA. Gareth's academic background includes a Bachelor's degree in Accounting and Finance from Solent University and a High School degree in Business Studies from Weymouth College.
This person is not in any teams
Intellia Therapeutics
9 followers
Intellia Therapeutics is a leading genome editing company whose mission is to develop potentially curative gene editing treatments that can positively transform the lives of people living with severe and life-threatening diseases.